Quidel Cp (QDEL) 22.80 $QDEL Quidel Shares Up 30.4%

New Post Public Reply Private Reply Replies (0) Message Board

Aug 1, 2016 at 3:01 AM

Quidel Cp (QDEL) 22.80 $QDEL

Quidel Shares Up 30.4% Since SmarTrend's Buy Recommendation (QDEL)
Comtex SmarTrend(R) - Fri Jul 29, 1:19PM CDT
SmarTrend identified an Uptrend for Quidel (NASDAQ:QDEL) on June 13th, 2016 at $17.97. In approximately 2 months, Quidel has returned 30.44% as of today's recent price of $23.44.
QDEL: 22.80 (-0.44)

Quidel to Present at the 36th Annual Canaccord Genuity Growth Conference
Marketwire Canada - Thu Jul 28, 3:30PM CDT
SAN DIEGO, CA--(Marketwired - July 28, 2016) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the 36th Annual Canaccord Genuity Growth Conference, to be held at the InterContinental Boston hotel in Boston, Massachusetts on Wednesday, August 10, 2016.
QDEL: 22.80 (-0.44)

Quidel Reports Second Quarter 2016 Financial Results
Marketwired - Wed Jul 27, 3:10PM CDT
SAN DIEGO, CA--(Marketwired - July 27, 2016) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the second quarter ended June 30, 2016.
QDEL: 22.80 (-0.44)

Zacks.com featured highlights: Lancaster Colony, Quidel, Klondex Mines, Honeywell International and Global Brass and Copper Holdings
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 8:30AM CDT
Zacks.com featured highlights: Lancaster Colony, Quidel, Klondex Mines, Honeywell International and Global Brass and Copper Holdings
KLDX: 4.74 (+0.24), HON: 116.33 (+0.57), BRSS: 28.32 (-0.22), QDEL: 22.80 (-0.44), LANC: 129.96 (+0.10)

5 Efficient Stocks to Enhance Your Portfolio Return
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 8:30AM CDT
A portfolio that seeks to provide significant exposure to securities of efficient companies is poised to perform better in any market condition.
KLDX: 4.74 (+0.24), HON: 116.33 (+0.57), BRSS: 28.32 (-0.22), QDEL: 22.80 (-0.44), LANC: 129.96 (+0.10)

Quidel (QDEL) Shares March Higher, Can It Continue?
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 5:52AM CDT
Quidel Corporation (QDEL) has been on the move lately as the stock has risen by 10.9% in the past four weeks, and it is currently trading well above its 20-Day SMA
QDEL: 22.80 (-0.44)

Upgrade Alert for Quidel (QDEL)
Comtex SmarTrend(R) - Tue Jun 14, 3:32AM CDT
Quidel (NASDAQ:QDEL) was upgraded from Market Perform to Outperform at Raymond James today. The stock closed yesterday at $18.10 on volume of 223,000 shares, above average daily volume of 153,000. Quidel Corporation discovers, develops, manufactures, and markets rapid diagnostic products for point-of-care detection of human medical conditions and illnesses. The Company's products provide diagnoses for acute and chronic conditions in the areas of women's health and infectious diseases. Quidel's products are sold to professionals and to consumers.
QDEL: 22.80 (-0.44)

Quidel to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
Marketwired - Thu Apr 28, 3:00PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the Bank of America Merrill Lynch 2016 Health Care Conference, to be held at the Encore at Wynn hotel in Las Vegas, Nevada on Tuesday, May 10, 2016.
QDEL: 22.80 (-0.44)

Quidel reports 1Q loss
Automated Insights - Wed Apr 27, 5:31PM CDT
SAN DIEGO (AP) _ Quidel Corp. (QDEL) on Wednesday reported a first-quarter loss of $3.4 million, after reporting a profit in the same period a year earlier.
QDEL: 22.80 (-0.44)

Quidel Reports First Quarter 2016 Financial Results
Marketwired - Wed Apr 27, 3:10PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the first quarter ended March 31, 2016.
QDEL: 22.80 (-0.44)

Q1 Earnings Lack Sheen: 5 MedTech Stocks to Bet On
Zacks Equity Research - Zacks Investment Research - Wed Apr 13, 3:55PM CDT
Medical is one of the few sectors in the S&P 500 that is expected to report growth in the first quarter.
ZBH: 131.14 (+3.67), ALGN: 89.15 (+3.87), GKOS: 34.96 (+0.21), QDEL: 22.80 (-0.44), INGN: 53.74 (+1.00)

Quidel to Hold First Quarter 2016 Financial Results Conference Call on April 27, 2016
Marketwired - Tue Apr 12, 3:30PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report first quarter 2016 financial results after market close on Wednesday, April 27, 2016.
QDEL: 22.80 (-0.44)

18.8% Return Seen to Date on SmarTrend Quidel Call (QDEL)
Comtex SmarTrend(R) - Wed Feb 10, 12:40PM CST
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on January 7th, 2016 at $19.12. In approximately 1 month, Quidel has returned 18.78% as of today's recent price of $15.53.
QDEL: 22.80 (-0.44)

Downgrade Alert for Quidel (QDEL)
Comtex SmarTrend(R) - Tue Feb 09, 7:13AM CST
Quidel (NASDAQ:QDEL) was downgraded from Buy to Hold at Canaccord Genuity today. The stock closed yesterday at $16.34 on volume of 285,000 shares, above average daily volume of 279,000. Quidel Corporation discovers, develops, manufactures, and markets rapid diagnostic products for point-of-care detection of human medical conditions and illnesses. The Company's products provide diagnoses for acute and chronic conditions in the areas of women's health and infectious diseases. Quidel's products are sold to professionals and to consumers.
QDEL: 22.80 (-0.44)

Quidel Announces Preliminary Revenue for Fourth Quarter 2015
Marketwired - Thu Jan 07, 5:37PM CST
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it expects revenues in the fourth quarter of 2015 to be between $52 million and $53 million.
QDEL: 22.80 (-0.44)

Can Quidel Corp. (QDEL) Keep the Earnings Streak Alive This Quarter?
Zacks Equity Research - Zacks Investment Research - Thu Dec 17, 7:38AM CST
Quidel Corp. (QDEL) has seen a nice short-term history of beating earnings estimates, and looks set to crush analyst expectations in its next earnings report.
QDEL: 22.80 (-0.44)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Laars Welcomes Women in Manufacturing to Facility Tour

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

VetsinTech's AI Training Boosts Military Careers

A New Spin on Engineering Careers Sometimes it feels like every corner I turn in this market maze, there’s something about AI. It’s not just chirping in the tech world anymore; it’s banging on the doors of sectors like engineering, aerospace, and manufacturing. And now, VetsinTech is tossing its hat into the AI ring with a fresh program aimed at blending military...

Montessori and Tech: A New Era of Integration

Reimagining Montessori with Technology Let's take a stroll down the road less traveled—the intersection of Montessori education and tech. For over a century, Montessori schools have valued individual child development, autonomy, and a purpose-driven environment. But let's face it, their technology hasn't always had the same handcrafted finesse. That's where illumine...

Honeywell Aerospace Faces Legal Turbulence in Fraud Case

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Montesodi 2023: A Fresh Chapter in Chianti Excellence

A Glass Filled with History and Nature's Whimsy When you pour a glass of Montesodi 2023, you’re not just tasting wine but a story—a saga that blends Tuscany’s rich vineyard history with last year's unpredictable weather. Marchesi Frescobaldi, a name that’s seen it all over its thousand years, has once again shown us how resilience and tradition can marry with...

TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

New American Funding Expands in Carolinas with Mullinix Move

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

Home Buying: Unmasking All the Real Budget Costs

Home Buying: More Costs Than Meets the Eye Let's face it, buying a home is no stroll in the park. It's a tangled web of numbers and surprises that can leave even the savviest buyer in a daze. Thank goodness for articles like the one from HelloNation featuring Serena LoPiccolo-Smith, which make the invisible visible when it comes to the financial intricacies of home...

Fluence Energy Faces Major Lawsuit Amid $3B Loss

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Omneky Outshines Competitors in AI Ad Scoring

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...